210 related articles for article (PubMed ID: 20013122)
1. [Grayzone lymphoma. Clinical relevance].
Hartmann S; Hansmann ML
Pathologe; 2010 Feb; 31(1):42-9. PubMed ID: 20013122
[TBL] [Abstract][Full Text] [Related]
2. Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.
Eberle FC; Salaverria I; Steidl C; Summers TA; Pittaluga S; Neriah SB; Rodriguez-Canales J; Xi L; Ylaya K; Liewehr D; Dunleavy K; Wilson WH; Hewitt SM; Raffeld M; Gascoyne RD; Siebert R; Jaffe ES
Mod Pathol; 2011 Dec; 24(12):1586-97. PubMed ID: 21822207
[TBL] [Abstract][Full Text] [Related]
3. [Lymph node pathology - an update].
Hartmann S; Hansmann ML
Pathologe; 2013 Feb; 34(1):34-44. PubMed ID: 23319007
[TBL] [Abstract][Full Text] [Related]
4. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
5. Aggressive B-cell lymphomas: how many categories do we need?
Said JW
Mod Pathol; 2013 Jan; 26 Suppl 1(0 1):S42-56. PubMed ID: 23154748
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma.
Calvo KR; Traverse-Glehen A; Pittaluga S; Jaffe ES
Adv Anat Pathol; 2004 Sep; 11(5):227-38. PubMed ID: 15322489
[TBL] [Abstract][Full Text] [Related]
7. [Grey zone lymphomas: limitations of the classification of aggressive B-cell lymphomas].
Ott MM; Horn H; Rosenwald A; Ott G
Pathologe; 2013 May; 34(3):225-32. PubMed ID: 23494279
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
[TBL] [Abstract][Full Text] [Related]
9. New developments in extracutaneous lymphomas.
Chott A; Raderer M
Semin Cutan Med Surg; 2000 Jun; 19(2):149-56. PubMed ID: 10892718
[TBL] [Abstract][Full Text] [Related]
10. Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.
Oschlies I; Burkhardt B; Salaverria I; Rosenwald A; d'Amore ES; Szczepanowski M; Koch K; Hansmann ML; Stein H; Möller P; Reiter A; Zimmermann M; Rosolen A; Siebert R; Jaffe ES; Klapper W
Haematologica; 2011 Feb; 96(2):262-8. PubMed ID: 20971819
[TBL] [Abstract][Full Text] [Related]
11. Difficult Diagnosis between B Cell Lymphoma and Classical Hodgkin's Lymphoma.
Rentas Torres Y; Rodríguez-López JL; Valentin M; Silva H
Bol Asoc Med P R; 2015; 107(3):98-101. PubMed ID: 26742206
[TBL] [Abstract][Full Text] [Related]
12. [Unclassified B-cell lymphomas with "grey zone" characteristics].
Chen DB; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):278-81. PubMed ID: 21616011
[No Abstract] [Full Text] [Related]
13. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
[TBL] [Abstract][Full Text] [Related]
14. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
15. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 monoclonal antibody (Rituximab) for therapy of mediastinal CD20-positive large B-cell non-Hodgkin lymphoma with a local tumor extension into the lung of a 10-year-old girl.
Culić S; Culić V; Armanda V; Kuljis D; Pesutić-Pisac V; Janković S
Pediatr Hematol Oncol; 2003 Jun; 20(4):339-44. PubMed ID: 12746167
[TBL] [Abstract][Full Text] [Related]
17. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma.
Frick M; Dörken B; Lenz G
Best Pract Res Clin Haematol; 2012 Mar; 25(1):3-12. PubMed ID: 22409819
[TBL] [Abstract][Full Text] [Related]
18. The biology of human lymphoid malignancies revealed by gene expression profiling.
Staudt LM; Dave S
Adv Immunol; 2005; 87():163-208. PubMed ID: 16102574
[TBL] [Abstract][Full Text] [Related]
19. Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?
Grant C; Dunleavy K; Eberle FC; Pittaluga S; Wilson WH; Jaffe ES
Curr Hematol Malig Rep; 2011 Sep; 6(3):157-63. PubMed ID: 21590365
[TBL] [Abstract][Full Text] [Related]
20. Morphological criteria in the classification of the malignant lymphomas.
Sheehan WW; Rappaport H
Proc Natl Cancer Conf; 1970; 6():59-71. PubMed ID: 4917735
[No Abstract] [Full Text] [Related]
[Next] [New Search]
